Moctanin

   
Google
 
Web NewDrugInformation.com

Moctanin


Drug - Moctanin
The trade name of the product as shown on the labeling.

Dosage - LIQUID; PERFUSION, BILIARY
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Monoctanoin
Multiple ingredients are in alphabetical order.

Strength - 100%
The potency of the active ingredient(s), Monoctanoin. May repeat for multiple part products.

Applicant - ETHITEK
The firm name holding legal responsibility for Moctanin. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 019368
The FDA assigned number to Moctanin. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Moctanin. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Oct 29, 1985
The date Moctanin was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Moctanin. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Moctanin is in. Format is RX, OTC, DISCN.

Applicant Full Name - Ethitek Pharmaceuticals Co
The full name of the firm holding legal responsibility for the new application of Moctanin.

Moctanin